HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US
Author:
Affiliation:
1. Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA
2. Complete HEOR Solutions (CHEORS), North Wales, PA, USA
3. Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA
Funder
Merck Sharp & Dohme LLC
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2161253
Reference58 articles.
1. A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion
2. Worldwide burden of cancer attributable to HPV by site, country and HPV type
3. American Academy of Pediatrics. HPV Vaccine Implementation Guidance; 2017.
4. Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population
5. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Contemporary provider perspectives on how to address HPV vaccine hesitancy in the US: A qualitative study;Vaccine: X;2024-10
2. Associations of mothers’ decisional conflicts and satisfaction with governmental health promotion materials with their daughters’ HPV vaccination uptake in China: A cross-sectional survey;Vaccine: X;2024-08
3. Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine;Pediatrics;2024-07-09
4. HPV vaccine standing orders and communication in primary care: A qualitative study;Vaccine;2024-07
5. Assessing the long-term implications of age 9 initiation of HPV vaccination on series completion by age 13–15 in the US: projections from an age-structured vaccination model;Frontiers in Pediatrics;2024-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3